APA (7th ed.) Citation

Krug, D., Vonthein, R., Schreiber, A., Boicev, A. D., Zimmer, J., Laubach, R., . . . Dunst, J. (2021). Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial. Strahlentherapie und Onkologie, 197(9), . https://doi.org/10.1007/s00066-020-01730-9

Chicago Style (17th ed.) Citation

Krug, David, et al. "Impact of Guideline Changes on Adoption of Hypofractionation and Breast Cancer Patient Characteristics in the Randomized Controlled HYPOSIB Trial." Strahlentherapie Und Onkologie 197, no. 9 (2021). https://doi.org/10.1007/s00066-020-01730-9.

MLA (9th ed.) Citation

Krug, David, et al. "Impact of Guideline Changes on Adoption of Hypofractionation and Breast Cancer Patient Characteristics in the Randomized Controlled HYPOSIB Trial." Strahlentherapie Und Onkologie, vol. 197, no. 9, 2021, https://doi.org/10.1007/s00066-020-01730-9.